Cargando…

Genetic Survey of Psilocybe Natural Products

Psilocybe magic mushrooms are best known for their main natural product, psilocybin, and its dephosphorylated congener, the psychedelic metabolite psilocin. Beyond tryptamines, the secondary metabolome of these fungi is poorly understood. The genomes of five species (P. azurescens, P. cubensis, P. c...

Descripción completa

Detalles Bibliográficos
Autores principales: Dörner, Sebastian, Rogge, Kai, Fricke, Janis, Schäfer, Tim, Wurlitzer, Jacob M., Gressler, Markus, Pham, Duyen N. K., Manke, David R., Chadeayne, Andrew R., Hoffmeister, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400892/
https://www.ncbi.nlm.nih.gov/pubmed/35583969
http://dx.doi.org/10.1002/cbic.202200249
_version_ 1784772845531824128
author Dörner, Sebastian
Rogge, Kai
Fricke, Janis
Schäfer, Tim
Wurlitzer, Jacob M.
Gressler, Markus
Pham, Duyen N. K.
Manke, David R.
Chadeayne, Andrew R.
Hoffmeister, Dirk
author_facet Dörner, Sebastian
Rogge, Kai
Fricke, Janis
Schäfer, Tim
Wurlitzer, Jacob M.
Gressler, Markus
Pham, Duyen N. K.
Manke, David R.
Chadeayne, Andrew R.
Hoffmeister, Dirk
author_sort Dörner, Sebastian
collection PubMed
description Psilocybe magic mushrooms are best known for their main natural product, psilocybin, and its dephosphorylated congener, the psychedelic metabolite psilocin. Beyond tryptamines, the secondary metabolome of these fungi is poorly understood. The genomes of five species (P. azurescens, P. cubensis, P. cyanescens, P. mexicana, and P. serbica) were browsed to understand more profoundly common and species‐specific metabolic capacities. The genomic analyses revealed a much greater and yet unexplored metabolic diversity than evident from parallel chemical analyses. P. cyanescens and P. mexicana were identified as aeruginascin producers. Lumichrome and verpacamide A were also detected as Psilocybe metabolites. The observations concerning the potential secondary metabolome of this fungal genus support pharmacological and toxicological efforts to find a rational basis for yet elusive phenomena, such as paralytic effects, attributed to consumption of some magic mushrooms.
format Online
Article
Text
id pubmed-9400892
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-94008922022-08-26 Genetic Survey of Psilocybe Natural Products Dörner, Sebastian Rogge, Kai Fricke, Janis Schäfer, Tim Wurlitzer, Jacob M. Gressler, Markus Pham, Duyen N. K. Manke, David R. Chadeayne, Andrew R. Hoffmeister, Dirk Chembiochem Research Articles Psilocybe magic mushrooms are best known for their main natural product, psilocybin, and its dephosphorylated congener, the psychedelic metabolite psilocin. Beyond tryptamines, the secondary metabolome of these fungi is poorly understood. The genomes of five species (P. azurescens, P. cubensis, P. cyanescens, P. mexicana, and P. serbica) were browsed to understand more profoundly common and species‐specific metabolic capacities. The genomic analyses revealed a much greater and yet unexplored metabolic diversity than evident from parallel chemical analyses. P. cyanescens and P. mexicana were identified as aeruginascin producers. Lumichrome and verpacamide A were also detected as Psilocybe metabolites. The observations concerning the potential secondary metabolome of this fungal genus support pharmacological and toxicological efforts to find a rational basis for yet elusive phenomena, such as paralytic effects, attributed to consumption of some magic mushrooms. John Wiley and Sons Inc. 2022-06-09 2022-07-19 /pmc/articles/PMC9400892/ /pubmed/35583969 http://dx.doi.org/10.1002/cbic.202200249 Text en © 2022 The Authors. ChemBioChem published by Wiley-VCH GmbH https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Dörner, Sebastian
Rogge, Kai
Fricke, Janis
Schäfer, Tim
Wurlitzer, Jacob M.
Gressler, Markus
Pham, Duyen N. K.
Manke, David R.
Chadeayne, Andrew R.
Hoffmeister, Dirk
Genetic Survey of Psilocybe Natural Products
title Genetic Survey of Psilocybe Natural Products
title_full Genetic Survey of Psilocybe Natural Products
title_fullStr Genetic Survey of Psilocybe Natural Products
title_full_unstemmed Genetic Survey of Psilocybe Natural Products
title_short Genetic Survey of Psilocybe Natural Products
title_sort genetic survey of psilocybe natural products
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400892/
https://www.ncbi.nlm.nih.gov/pubmed/35583969
http://dx.doi.org/10.1002/cbic.202200249
work_keys_str_mv AT dornersebastian geneticsurveyofpsilocybenaturalproducts
AT roggekai geneticsurveyofpsilocybenaturalproducts
AT frickejanis geneticsurveyofpsilocybenaturalproducts
AT schafertim geneticsurveyofpsilocybenaturalproducts
AT wurlitzerjacobm geneticsurveyofpsilocybenaturalproducts
AT gresslermarkus geneticsurveyofpsilocybenaturalproducts
AT phamduyennk geneticsurveyofpsilocybenaturalproducts
AT mankedavidr geneticsurveyofpsilocybenaturalproducts
AT chadeayneandrewr geneticsurveyofpsilocybenaturalproducts
AT hoffmeisterdirk geneticsurveyofpsilocybenaturalproducts